{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:11:49Z","timestamp":1786590709509,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Great Ormond Street Children's Charity Award Number W1075D"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41433-022-02096-1","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T19:14:16Z","timestamp":1652469256000},"page":"1178-1183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Visual outcomes and predictors in optic pathway glioma: a single centre study"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-4104","authenticated-orcid":false,"given":"R.","family":"Bowman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. L.","family":"Prise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Handley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5911-0541","authenticated-orcid":false,"given":"K.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mankad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"O\u2019Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Opocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hargrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"key":"2096_CR1","unstructured":"Central Brain Tumor Registry of the United States. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004\u20132006. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2010."},{"key":"2096_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ana.410410204","volume":"41","author":"R Listernick","year":"1997","unstructured":"Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol. 1997;41:143\u20139.","journal-title":"Ann Neurol"},{"key":"2096_CR3","doi-asserted-by":"publisher","first-page":"x1","DOI":"10.1093\/neuonc\/nou327","volume":"16","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, de Blank PM, Kruchko C, Petersen CM, Liao P, Finlay JL, et al. Alex\u2019s Lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011. Neuro-Oncol. 2015;16:x1\u201336.","journal-title":"Neuro-Oncol"},{"key":"2096_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ana.21107","volume":"61","author":"R Listernick","year":"2007","unstructured":"Listernick R, Ferner RE, Liu GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol. 2007;61:189\u201398.","journal-title":"Ann Neurol"},{"key":"2096_CR5","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro-Oncol. 2014;16:iv1\u201363.","journal-title":"Neuro-Oncol"},{"key":"2096_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ajmg.a.20650","volume":"127A","author":"MA Blazo","year":"2004","unstructured":"Blazo MA, Lewis RA, Chintagumpala MM, Frazier M, McCluggage C, Plon SE. Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1. Am J Med Genet A. 2004;127A:224\u20139.","journal-title":"Am J Med Genet A"},{"key":"2096_CR7","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/onc.2013.148","volume":"33","author":"Y-H Chen","year":"2014","unstructured":"Chen Y-H, Gutmann DH. The molecular and cell biology of pediatric low-grade gliomas. Oncogene. 2014;33:2019\u201326.","journal-title":"Oncogene"},{"key":"2096_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2217\/cns.12.47","volume":"2","author":"I Fried","year":"2013","unstructured":"Fried I, Tabori U, Tihan T, Reginald A, Bouffet E. Optic pathway gliomas: a review. CNS Oncol. 2013;2:143\u201359.","journal-title":"CNS Oncol"},{"key":"2096_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/08830738030180070401","volume":"18","author":"E Czyzyk","year":"2003","unstructured":"Czyzyk E, J\u00f3zwiak S, Roszkowski M, Schwartz RA. Optic pathway gliomas in children with and without neurofibromatosis 1. J Child Neurol. 2003;18:471\u20138.","journal-title":"J Child Neurol"},{"key":"2096_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97\u2013109.","journal-title":"Acta Neuropathol"},{"key":"2096_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","volume":"89","author":"JM Friedman","year":"1999","unstructured":"Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89:1\u20136.","journal-title":"Am J Med Genet"},{"key":"2096_CR12","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/neuonc\/nos076","volume":"14","author":"MJ Fisher","year":"2012","unstructured":"Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, et al. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro-Oncol. 2012;14:790\u20137.","journal-title":"Neuro-Oncol"},{"key":"2096_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0887-8994(02)00628-8","volume":"28","author":"SL Tow","year":"2003","unstructured":"Tow SL, Chandela S, Miller NR, Avellino AM. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol. 2003;28:262\u201370.","journal-title":"Pediatr Neurol"},{"key":"2096_CR14","first-page":"929","volume":"91","author":"RA Lewis","year":"1984","unstructured":"Lewis RA, Gerson LP, Axelson KA, Riccardi VM, Whitford RP. von Recklinghausen neurofibromatosis. II. Incid Opt gliomata Ophthalmol. 1984;91:929\u201335.","journal-title":"Incid Opt gliomata Ophthalmol"},{"key":"2096_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ajo.2003.09.055","volume":"137","author":"GT Liu","year":"2004","unstructured":"Liu GT, Brodsky MC, Phillips PC, Belasco J, Janss A, Golden JC, et al. Optic radiation involvement in optic pathway gliomas in neurofibromatosis. Am J Ophthalmol. 2004;137:407\u201314.","journal-title":"Am J Ophthalmol"},{"key":"2096_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3171\/jns.1997.86.5.0747","volume":"86","author":"RJ Packer","year":"1997","unstructured":"Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg. 1997;86:747\u201354.","journal-title":"J Neurosurg"},{"key":"2096_CR17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/pbc.22748","volume":"55","author":"M Campagna","year":"2010","unstructured":"Campagna M, Opocher E, Viscardi E, Calderone M, Severino SM, Cermakova I, et al. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1. Pediatr Blood Cancer. 2010;55:1083\u20138.","journal-title":"Pediatr Blood Cancer"},{"key":"2096_CR18","doi-asserted-by":"publisher","first-page":"e0212107","DOI":"10.1371\/journal.pone.0212107","volume":"14","author":"J Rakotonjanahary","year":"2019","unstructured":"Rakotonjanahary J, Gravier N, Lambron, De Carli E, Toulgoat F, Delion M, et al. Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy\u2014Analysis of a French pediatric historical cohort. PLoS One 2019. 2019;14:e0212107. Epub 2019 Mar 8","journal-title":"PLoS One 2019"},{"key":"2096_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/WNO.0b013e31822aef82","volume":"31","author":"RA Avery","year":"2011","unstructured":"Avery RA, Fisher MJ, Liu GT. Optic pathway gliomas. J Neuroophthalmol. 2011;31:269\u201378.","journal-title":"J Neuroophthalmol"},{"key":"2096_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11060-013-1300-6","volume":"116","author":"RA Avery","year":"2014","unstructured":"Avery RA, Hardy KK. Vision specific quality of life in children with optic pathway gliomas. J Neurooncol. 2014;116:341\u20137. Jan","journal-title":"J Neurooncol"},{"key":"2096_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/jamaophthalmol.2013.5819","volume":"132","author":"RA Avery","year":"2014","unstructured":"Avery RA, Hwang EI, Jakacki RI, Packer RJ. Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab. JAMA Ophthalmol. 2014;132:111\u20134. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.5819.","journal-title":"JAMA Ophthalmol"},{"key":"2096_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/nop\/npz076","volume":"7","author":"VM Lu","year":"2020","unstructured":"Lu VM, Welby JP, Nesvick CL, Daniels DJ. Efficacy and safety of bevacizumab in progressive pediatric low-grade glioma: a systematic review and meta-analysis of outcome rates. Neurooncol Pract. 2020;7:359\u201368. https:\/\/doi.org\/10.1093\/nop\/npz076. Epub 2020 Feb 3.","journal-title":"Neurooncol Pract"},{"key":"2096_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/cam4.1799","volume":"8","author":"N Zhukova","year":"2019","unstructured":"Zhukova N, Rajagopal R, Lam A, Coleman L, Shipman P, Walwyn T, et al. Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma. Cancer Med. 2019;8:40\u201350. https:\/\/doi.org\/10.1002\/cam4.1799. Epub 2018 Dec 19.","journal-title":"Cancer Med"},{"key":"2096_CR24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","volume":"20","author":"J Fangusaro","year":"2019","unstructured":"Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, et al. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol 2019;20:1011\u201322. https:\/\/doi.org\/10.1016\/S1470-2045(19)30277-3. Epub 2019 May 28.","journal-title":"Lancet Oncol"},{"key":"2096_CR25","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1158\/1078-0432.CCR-19-2177","volume":"25","author":"DR Hargrave","year":"2019","unstructured":"Hargrave DR, Bouffet E, Tabori U, Broniscer A, Cohen KJ, Hansford JR, et al. Efficacy and safety of dabrafenib in pediatric patients with BRAF V600 mutation-positive relapsed or refractory low-grade glioma: results from a phase I\/IIa study. Clin Cancer Res. 2019;25:7303\u201311. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2177.","journal-title":"Clin Cancer Res"},{"key":"2096_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ajo.2010.08.046","volume":"151","author":"RA Avery","year":"2011","unstructured":"Avery RA, Liu GT, Fisher MJ, Quinn GE, Belasco JB, Phillips PC, et al. Retinal nerve fibre layer thickness in children with optic pathway gliomas. Am J Ophthalmol. 2011;151:542\u20139.","journal-title":"Am J Ophthalmol"},{"key":"2096_CR27","doi-asserted-by":"publisher","unstructured":"Gu S, Glaug N, Cnaan A, Packer RJ, Avery RA. Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas. Invest Ophthalmol Vis Sci. 2014;55:1402\u20138. https:\/\/doi.org\/10.1167\/iovs.13-13119.","DOI":"10.1167\/iovs.13-13119"},{"key":"2096_CR28","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1167\/iovs.06-0429","volume":"48","author":"BC Chang","year":"2007","unstructured":"Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, et al. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. Invest Ophthalmol Vis Sci. 2007;48:2895\u2013902.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2096_CR29","doi-asserted-by":"publisher","first-page":"8112","DOI":"10.1167\/iovs.13-13093","volume":"54","author":"R Parrozzani","year":"2013","unstructured":"Parrozzani R, Clementi M, Kotsafti O, Miglionico G, Trevisson E, Orlando G, et al. Optical coherence tomography in the diagnosis of optic pathway gliomas. Invest Ophthalmol Vis Sci. 2013;54:8112\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2096_CR30","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.ejca.2010.03.028","volume":"46","author":"L Moreno","year":"2010","unstructured":"Moreno L, Bautista F, Ashley S, Duncan C, Zacharoulis S. Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence. Eur J Cancer. 2010;46:2253\u20139.","journal-title":"Eur J Cancer"},{"key":"2096_CR31","first-page":"noaa153","volume":"6","author":"AA Azizi","year":"2020","unstructured":"Azizi AA, Walker DA, Liu JF, Sehested A, Jaspan T, Pemp B, et al. NF1 optic pathway glioma. Analysing risk factors for visual outcome and indications to treat.; SIOPE NF1 OPG Nottingham, UK, Workshop 2014. Neuro Oncol. 2020;6:noaa153.","journal-title":"Neuro Oncol"},{"key":"2096_CR32","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1136\/bjophthalmol-2017-311305","volume":"102","author":"K Falzon","year":"2018","unstructured":"Falzon K, Drimtzias E, Picton S, Simmons I. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort. Br J Ophthalmol. 2018;102:1367\u201371. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311305. Epub 2018 Jan 17","journal-title":"Br J Ophthalmol"},{"key":"2096_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/archneurpsyc.1958.02340060003001","volume":"79","author":"HW Dodge","year":"1958","unstructured":"Dodge HW, Love JG, Craig WM, Dockerty MB, Kearns TP, Holman CB, et al. Gliomas of the optic nerves. AMA Arch Neurol Psychiatry. 1958;79:607\u201321.","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"2096_CR34","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ajo.2012.08.010","volume":"155","author":"SE Yanni","year":"2013","unstructured":"Yanni SE, Wang J, Cheng CS, Locke KI, Wen Y, Birch DG, et al. Normative reference ranges for the retinal nerve fiber layer, macula, and retinal layer thicknesses in children. Am J Ophthalmol. 2013;155:354\u201360.e1. https:\/\/doi.org\/10.1016\/j.ajo.2012.08.010. Epub 2012 Nov 3","journal-title":"Am J Ophthalmol"},{"key":"2096_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10633-016-9553-y","volume":"133","author":"JV Odom","year":"2016","unstructured":"Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Mizota A, et al. International Society for Clinical Electrophysiology of V. ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol. 2016;133:1\u20139.","journal-title":"Doc Ophthalmol"},{"key":"2096_CR36","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/bjophthalmol-2013-304587","volume":"98","author":"C Bunce","year":"2014","unstructured":"Ophthalmic statistics note 1: unit of analysis, Bunce C, Patel KV, Xing W, Freemantle N, Dor\u00e9 CJ. Ophthalmic statistics group. Br J Ophthalmol 2014;98:408\u201312. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304587. Epub 2013 Dec 19.","journal-title":"Br J Ophthalmol"},{"key":"2096_CR37","unstructured":"Vision impairment and blindness [Internet]. Who.int. 2019 [cited 12 August 2020]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment"},{"key":"2096_CR38","doi-asserted-by":"publisher","unstructured":"Hamilton R, Bach M, Heinrich SP, Hoffmann MB, Odom JV, McCulloch DL, et al. VEP estimation of visual acuity: a systematic review. Doc Ophthalmol. 2020. https:\/\/doi.org\/10.1007\/s10633-020-09770-3. Online ahead of print.","DOI":"10.1007\/s10633-020-09770-3"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02096-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02096-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02096-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T16:07:45Z","timestamp":1681402065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02096-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2096"],"URL":"https:\/\/doi.org\/10.1038\/s41433-022-02096-1","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"assertion":[{"value":"19 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}